Search for a command to run...
<h3>Background</h3> Parkinson’s disease (PD) is a chronic, progressive neurological movement disorder. Prevalence in 2023 was calculated at 153,000 and predicted to increase to 172,000 by 2030 (Parkinson’s UK. Parkinson’s Prevalence in the United Kingdom 2023. [internet]). NICE guidance recommends palliative care should be considered throughout all phases of the illness (National Institute for Health and Care Excellence. Parkinson’s disease in adults. [NG71] NICE; 2017). Despite the benefits palliative care could offer, there is no consensus on how it should be delivered (Garon, Weck, Rosqvist, et al. Palliat Med. 2024;38(1):57-68). <h3>Aims</h3> Improve understanding of these movement disorder conditions. Improve networking with local specialists for better oversight of this patient group. Establish a clear pathway for referral and care delivery, ensuring timely intervention. <h3>Method</h3> A Movement Disorders Palliative Care multidisciplinary team (MDT) started involving both hospices in the city; Palliative Consultants, Community Clinical Nurse Specialists and Allied Health Professionals, local NHS trust Consultants, Parkinson’s Clinical Nurse Specialists and Parkinson’s UK representative. Monthly MDT meetings for discussion including medication management, therapy, psychological, and social review. Opportunity for joint home visits with Medicine for Older People Consultant and hospice Clinical Nurse Specialists, as well as hospice inpatient admissions for medication rationalisation and palliative rehabilitation. <h3>Results</h3> MDTs have improved communication, networking and knowledge of the city-wide service. Development of Movement Disorders patient pathway, zero inappropriate hospital admissions and 38% of patients admitted to hospice for symptom management or end of life care. Increased training and development opportunities for hospice staff. Improved management of complex patients including medication rationalisation to increase benefit and reduce burden, consider best practice opportunities and encourage early involvement in specialist palliative care. 100% of this patient group achieved their preferred place of death. <h3>Conclusion</h3> Improved outcomes for patients and their families have been the main drive for this approach. Significant increase in knowledge and confidence of hospice staff in the management of this patient group. This ongoing collaboration has achieved such patient and staff benefits that we are now implementing the same model to other non-cancer neurological conditions (MND and advanced MS patients).